PROTAC
Read More about this categoryShow Less
The PROTAC molecule itself contains three distinct portions: a ligand for binding to the target protein, a ligand for binding to an E3 ligase, and a linker joining these two ligands.
PROTACs (proteolysis-targeting chimaeras) are bifunctional molecules that bring a target protein into spatial proximity with an E3 ubiquitin ligase to trigger target ubiquitination and subsequent proteasomal degradation. Effective redirection of ligase poly-ubiquitination activity toward a new substrate protein requires formation of a ligase:PROTAC:target ternary complex, an intermediate species that is crucial to the cellular activity of degrader molecules. A characteristic feature of PROTACs mode of action is their sub-stoichiometric catalytic activity that alleviates the requirement for target engagement and occupancy of traditional inhibitors. New PROTAC molecules designed guided by the crystal structure show exquisite selectivity for inducing cellular depletion of Brd4 over its BET family members Brd2 and Brd3.
Products Related to PROTAC(305)
- GC81514PROTAC SMARCA2 degrader-35CAS: 3032998-97-0Purity: >98.00%
PROTAC SMARCA2 degrader-35 (Compound 43) is a selective SMARCA2 PROTAC degrader with a DC 50 < 0.1 μM for SMARCA2.
- GC81522WWZ-11-098Purity: >98.00%
WWZ-11-098 is a selective CDK6 PROTAC degrader with DC 50 of 2.6 nM.
- GC81638PROTAC GPX4 degrader-5CAS: 3119292-91-7Purity: >95.00%
PROTAC GPX4 degrader-5 (compound N15) is an efficient and highly selective PROTAC GPX4 degrader ( DC 50 = 28 nM).
- GC81862YJ1206 TFAPurity: >98.00%
YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader.
- GC81882PROTAC CARM1 degrader-1 TFAPurity: >98.00%
PROTAC CARM1 degrader-1 TFA is a highly selective CARM1 PROTAC degrader, with a DC 50 of 8.1 nM in MCF‑7 cells.
- GC91582Pomalidomide 4'-PEG5-amine (hydrochloride)CAS: 2357117-23-6Purity: >95.00%
Pomalidomide 4’-PEG5-amine is a PEGylated form of the cereblon (CRBN) inhibitor pomalidomide .
- GC91584Pomalidomide 4'-alkylC6-amine (hydrochloride)CAS: 2375194-37-7Purity: >98.00%
Pomalidomide 4'-alkylC6-amine is a building block in the synthesis of proteolysis-targeting chimeras (PROTACs) and a derivative of the cereblon inhibitor pomalidomide .
- GC91586PROTAC RAF Degrader 1CAS: 2413035-41-1Purity: >98.00%
PROTAC RAF degrader 1 is a proteolysis-targeting chimera (PROTAC) that contains the inhibitor of mutant V600E and wild-type B-RAF vemurafenib (PLX4032; ) conjugated to VHL ligand 1 .
- GF04054PROTAC CDK9 degrader-4CAS: 2411021-01-5Purity: >95.00%
PROTAC CDK9 degrader-4 is a PROTAC protein degrader that targets CDK9 (cyclin-dependent kinase 9).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC81461 | FPP29 | - | >99.00% | |
FPP29 is a potent peptide-based FOXM1 PROTAC degrader. | ||||
| GC81512 | dCDK9-202 | - | >98.50% | |
dCDK9-202 is a CDK9 PROTAC degrader with a DC 50 of 3.5 nM. | ||||
| GC81514 | PROTAC SMARCA2 degrader-35 | 3032998-97-0 | >98.00% | |
PROTAC SMARCA2 degrader-35 (Compound 43) is a selective SMARCA2 PROTAC degrader with a DC 50 < 0.1 μM for SMARCA2. | ||||
| GC81522 | WWZ-11-098 | - | >98.00% | |
WWZ-11-098 is a selective CDK6 PROTAC degrader with DC 50 of 2.6 nM. | ||||
| GC81637 | EBET-1593 | 3031540-97-0 | >98.00% | |
EBET-1593 is a BET PROTAC degrader. | ||||
| GC81638 | PROTAC GPX4 degrader-5 | 3119292-91-7 | >95.00% | |
PROTAC GPX4 degrader-5 (compound N15) is an efficient and highly selective PROTAC GPX4 degrader ( DC 50 = 28 nM). | ||||
| GC81639 | SH-26 | - | >98.00% | |
SH-26 is a PHD1 PROTAC degrader with DC 50 s of 1.06 μM, 4.16 μM and 4.91 μM in MDA-MB-231, HepG2 and HEK-293T cells, respectively. | ||||
| GC81720 | DDO3602 | - | >98.00% | |
DDO3602 is a PARP1 HSPTAC ( HSP90 -mediated proteolysis-targeting chimera) degrader, with a DC 50 of 490.3 nM against PARP1; its K d values for PARP1 and HSP90 are 66.5 nM and 1.64 nM, respectively. | ||||
| GC81732 | iAfaPhos1 | - | >98.00% | |
iAfaPhos1 is a FKBP12F36V epimer ligand. | ||||
| GC81862 | YJ1206 TFA | - | >98.00% | |
YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader. | ||||
| GC81882 | PROTAC CARM1 degrader-1 TFA | - | >98.00% | |
PROTAC CARM1 degrader-1 TFA is a highly selective CARM1 PROTAC degrader, with a DC 50 of 8.1 nM in MCF‑7 cells. | ||||
| GC91440 | Dth | - | >95.00% | |
Dth is a proteolysis-targeting chimera (PROTAC) composed of the fluorescent probe for RNA DFHBI and the immunomodulatory compound thalidomide . | ||||
| GC91442 | C-02 | - | >95.00% | |
C-02 is a proteolysis-targeting chimera (PROTAC) composed of the hexokinase inhibitor lonidamine linked to the cereblon ligand thalidomide . | ||||
| GC91582 | Pomalidomide 4'-PEG5-amine (hydrochloride) | 2357117-23-6 | >95.00% | |
Pomalidomide 4’-PEG5-amine is a PEGylated form of the cereblon (CRBN) inhibitor pomalidomide . | ||||
| GC91584 | Pomalidomide 4'-alkylC6-amine (hydrochloride) | 2375194-37-7 | >98.00% | |
Pomalidomide 4'-alkylC6-amine is a building block in the synthesis of proteolysis-targeting chimeras (PROTACs) and a derivative of the cereblon inhibitor pomalidomide . | ||||
| GC91586 | PROTAC RAF Degrader 1 | 2413035-41-1 | >98.00% | |
PROTAC RAF degrader 1 is a proteolysis-targeting chimera (PROTAC) that contains the inhibitor of mutant V600E and wild-type B-RAF vemurafenib (PLX4032; ) conjugated to VHL ligand 1 . | ||||
| GF04054 | PROTAC CDK9 degrader-4 | 2411021-01-5 | >95.00% | |
PROTAC CDK9 degrader-4 is a PROTAC protein degrader that targets CDK9 (cyclin-dependent kinase 9). | ||||
